Evidence map›Paper›PMID 38489140›Full record

ArticleAIDS and behavior2024

Intersectional Stigma, Fear of Negative Evaluation, Depression, and ART Adherence Among Women Living with HIV Who Engage in Substance Use: A Latent Class Serial Mediation Analysis.

Kristi Lynn Stringer, Andrea Norcini Pala, Robert L Cook, Mirjam-Colette Kempf, Deborah Konkle-Parker, Tracey E Wilson, Phyllis C Tien, Gina Wingood, Torsten B Neilands, Mallory O Johnson and 4 more

Open access · greenAbstract read
In one paragraph

Article in AIDS and behavior, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 10 institutions in 3 countries.

Kristi Lynn Stringer *Department of Health and Human Performance, Community and Public Health, Middle Tennessee State University, Murfreesboro, TN, 37132, USA. Kristi.stringer@Mtsu.edu.ORCID http://orcid.org/0000-0001-6181-5789
Andrea Norcini Pala *Columbia School of Social Work, Columbia University, New York, NY, USA.
Robert L CookDepartment of Epidemiology, Colleges of Public Health and Health Professions and Medicine, University of Florida, Gainesville, FL, USA.
Mirjam-Colette KempfSchools of Nursing, Public Health, and Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
Deborah Konkle-ParkerSchools of Nursing, Medicine and Population Health, University of Mississippi Medical Center, Oxford, MS, USA.
Tracey E WilsonDepartment of Community Health Sciences, School of Public Health, State University of New York Downstate Health Sciences University, Brooklyn, NY, USA.
Phyllis C TienDepartment of Medicine, Department of Veteran Affairs Medical Center, University of California, San Francisco and Medical Service, San Francisco, CA, USA.
Gina WingoodDepartment of Sociomedical Sciences, Columbia University Mailman School of Public Health, New York City, NY, USA.
Torsten B NeilandsDivision of Prevention Science, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.
Mallory O JohnsonDivision of Prevention Science, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.
Carmen H LogieFactor-Inwentash Faculty of Social Work, University of Toronto, Toronto, ON, USA.
Sheri D WeiserDivision of HIV, ID and Global Medicine, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.
Janet M TuranDepartment of Health Policy and Organization, School of Public Health, University of Alabama at Birmingham, Birmingham, AL, USA.
Bulent TuranCollege of Social Sciences and Humanities, Psychology, Koc University, Istanbul, Turkey.
University of California, San Francisco · USColumbia University · USKoç University · TRMiddle Tennessee State University · USSan Francisco VA Medical Center · USState University of New York · USUniversity of Alabama at Birmingham · USUniversity of Florida · USUniversity of Mississippi Medical Center · USWomen's College Hospital · CA

Funding

UCLA Clinical Translational Science InstituteUL1TR001881 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ARLEEN F. BROWN, ARASH NAEIM · 2016 to 2026
$118.1M
Virology CoreP30AI027767 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Latesha Ellen Elopre · 1988 to 2026
$84.1M
Engaging University of California Stakeholders for Biorespository ResearchUL1TR000004 · NCATS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GRANDIS, JENNIFER RUBIN · 2012 to 2015
$78.0M
Virology, Immunology, and Microbiology CoreP30AI050410 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DAVID M. MARGOLIS · 2001 to 2026
$76.9M
Virology and Molecular Biomarkers CoreP30AI050409 · NIAID · EMORY UNIVERSITY · PI Ann M Chahroudi, Colleen F Kelley · 2002 to 2026
$74.0M
QAQC Johns Hopkins Institute for Clinical and Translational ResearchUL1TR003098 · NCATS · JOHNS HOPKINS UNIVERSITY · PI FORD, DANIEL ERNEST · 2019 to 2023
$57.7M
SF Bay Area MACS/WIHS Combined Cohort StudyU01HL146242 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Bradley E Aouizerat, Jennifer Cohen Price · 2019 to 2026
$36.3M
Sex differences in the role of multi-omicsin HIV-associated carotid artery atherosclerosisU01HL146193 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI Stephen J Gange, Elizabeth Topper · 2019 to 2026
$35.8M
University of Miami Developmental Center for AIDS Research (D-CFAR)P30AI073961 · NIAID · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI GWENDOLYN Barbara SCOTT · 2007 to 2026
$33.8M
MACS/WIHS Combined Cohort Study Clinical Research SiteU01HL146241 · NHLBI · EMORY UNIVERSITY · PI Cecile Delille Lahiri, Anandi Nayan Sheth · 2019 to 2026
$24.2M
UAB-MISS MACS/WIHS Combined Cohort StudyU01HL146192 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI James Benjamin Brock, MIRJAM-COLETTE KEMPF · 2019 to 2026
$23.9M
University of Miami Developmental HIV/AIDS Mental Health Research Center (D-ARC)P30MH116867 · NIMH · UNIVERSITY OF MIAMI CORAL GABLES · PI SAFREN, STEVEN A · 2019 to 2023
$6.5M
Division of Intramural Research, National Institute of Allergy and Infectious Diseases P30-AI-027767Division of Intramural Research, National Institute of Allergy and Infectious Diseases P30-AI-050409Division of Intramural Research, National Institute of Allergy and Infectious Diseases P30-AI-073961National Institute of Allergy and Infectious Diseases P30-AI-050410NCATS NIH HHS UL1 TR000004NCATS NIH HHS UL1-TR000004NCATS NIH HHS UL1 TR001881NCATS NIH HHS UL1-TR001881NCATS NIH HHS UL1 TR003098NCATS NIH HHS UL1-TR003098NHLBI NIH HHS U01 HL146192NHLBI NIH HHS U01-HL146192NHLBI NIH HHS U01 HL146193NHLBI NIH HHS U01 HL146241NHLBI NIH HHS U01-HL146241NHLBI NIH HHS U01 HL146242NHLBI NIH HHS U01-HL146242NIAID NIH HHS P30 AI027767NIAID NIH HHS P30 AI050409NIAID NIH HHS P30 AI050410NIAID NIH HHS P30 AI073961NIDA NIH HHS R03 DA052180NIDA NIH HHS R03DA052180NIDA NIH HHS R25 DA037190NIDA NIH HHS R25DA037190NIMH NIH HHS K01 MH125724NIMH NIH HHS K01MH125724NIMH NIH HHS P30 MH116867NIMH NIH HHS P30-MH-116867NIMH NIH HHS R01 MH131177NIMH NIH HHS R01MH131177
6 · The paper itself

Abstract

Women Living with HIV (WLHIV) who use substances face stigma related to HIV and substance use (SU). The relationship between the intersection of these stigmas and adherence to antiretroviral therapy (ART), as well as the underlying mechanisms, remains poorly understood. This study aimed to examine the association between intersectional HIV and SU stigma and ART adherence, while also exploring the potential role of depression and fear of negative evaluation (FNE) by other people in explaining this association. We analyzed data from 409 WLHIV collected between April 2016 and April 2017, Using Multidimensional Latent Class Item Response Theory analysis. We identified five subgroups (i.e., latent classes [C]) of WLHIV with different combinations of experienced SU and HIV stigma levels: (C1) low HIV and SU stigma; (C2) moderate SU stigma; (C3) higher HIV and lower SU stigma; (C4) moderate HIV and high SU stigma; and (C5) high HIV and moderate SU stigma. Medication adherence differed significantly among these classes. Women in the class with moderate HIV and high SU stigma had lower adherence than other classes. A serial mediation analysis suggested that FNE and depression symptoms are mechanisms that contribute to explaining the differences in ART adherence among WLHIV who experience different combinations of intersectional HIV and SU stigma. We suggest that FNE is a key intervention target to attenuate the effect of intersectional stigma on depression symptoms and ART adherence, and ultimately improve health outcomes among WLHIV.

Indexed as

DepressionDrug MonitoringFearHIV InfectionsMedication AdherenceSocial StigmaSubstance-Related DisordersAdultAnti-HIV AgentsCross-Sectional StudiesFemaleHumansLatent Class AnalysisMediation AnalysisMiddle AgedAnti-HIV AgentsDepressionFear of negative evaluationStigmaSubstance use

Identifiers

PMID38489140
PMCPMC11781310
OpenAlexW4392850438

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.